Sunburn, bug bites and stings, rashes, and other skin conditions are more common in the summer.

The FDA has granted accelerated approval to Avmapki (avutometinib) plus Fakzynja (defactinib) for the treatment of KRAS-mutated recurrent low-grade serous ovarian cancer.

The rainy weather may bring relief from the summer heat, but they also cause trouble for your skin. From oily breakouts to itchy rashes and fungal infections, monsoon season can be tough on your skin ...

Isotretinoin Oral isotretinoin is a synthetic vitamin A analog that should be considered for all patients with moderate-or-severe recalcitrant acne, provided there are no contraindications. It is ...

The scope for the development of novel acne therapies appears promising. Research into acne pathogenesis has clearly demonstrated that acne is a T-cell-mediated condition, and with this in mind ...

Cobimetinib in ECD patients is associated with acneiform rashes, fatigue, and diarrhea, and rarely with thrombocytopenia, cytolysis, edema, and hypertension (111). Table 5 summarizes the topical and ...

A cardiologist who specialkises in metabolic diseases such as diabetes has explained the unusual symptoms of poor gut health that could indicate a wide, serious, health problem. Dr Alok Chopra ...

Lutris Pharma’s lead asset, LUT014, a topical B-Raf Inhibitor, is a proprietary, first-in-class, small molecule, which has completed enrollment in a phase 2 clinical trial in metastatic colorectal ...

Presentation Title: A double-blind placebo-controlled randomized phase 2 clinical trial to assess the efficacy of a topical BRAF inhibitor for acneiform rash toxicities from anti-EGFR therapies ...

Presentation Details: Presentation Title: A double-blind placebo-controlled randomized phase 2 clinical trial to assess the efficacy of a topical BRAF inhibitor for acneiform rash toxicities from ...